Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Juillet 2023 - 10:05PM
Business Wire
IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on July 3,
2023, the Company granted equity-based awards pursuant to the
Company’s 2019 Inducement Stock Incentive Plan to 23 newly-hired,
non-executive employees. These inducement grants were approved by
the Company’s compensation and talent strategy committee pursuant
to a delegation by the Company’s board of directors and were made
as a material inducement to each employee’s acceptance of
employment with the Company in accordance with Nasdaq Listing Rule
5635(c)(4) as a component of his or her employment
compensation.
The inducement grants consisted of 124,860 restricted stock
units for shares of the Company’s common stock. The restricted
stock units vest with respect to 25% of the shares underlying the
units on July 1, 2024 and 6.25% of the shares underlying the units
on the first day of each of the subsequent 12 calendar quarters
(October 1, 2024, January 2, 2025, April 1, 2025, July 1, 2025,
October 1, 2025, January 2, 2026, April 1, 2026, July 1, 2026,
October 1, 2026, January 2, 2027, April 1, 2027 and July 1, 2027).
The inducement grants are subject to the terms and conditions of
award agreements covering the grants and the Company’s 2019
Inducement Stock Incentive Plan.
Iveric Bio
Iveric Bio is a science-driven biopharmaceutical company focused
on the discovery and development of novel treatments for retinal
diseases with significant unmet medical needs. The Company is
committed to having a positive impact on patients’ lives by
delivering high-quality, safe and effective treatments designed to
address debilitating retinal diseases including earlier stages of
age-related macular degeneration. For more information on the
Company, please visit www.ivericbio.com.
ISEE-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230705910642/en/
Investor / Media Contact: Iveric Bio Kathy Galante Senior
Vice President, Investor Relations kathy.galante@ivericbio.com
Media Contact: Jeannie Neufeld Senior Director, Public
Relations and Communications Jeannie.neufeld@ivericbio.com
IVERIC bio (NASDAQ:ISEE)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
IVERIC bio (NASDAQ:ISEE)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025
